Ying Chang

1.1k citations
6 papers · 490 indexed · 1 hit paper · h-index 5
Topics
SARS-CoV-2 and COVID-19 Research (4 papers)Animal Virus Infections Studies (3 papers)Immunotherapy and Immune Responses (2 papers)

In The Last Decade

Ying Chang

6 papers receiving 478 citations

Hit Papers

A Bivalent Omicron-Containing Booster Vaccine against Cov...20222026202320242022100200300

Peers

Ying Chang
Comparison fields: 5 of 48
  • Infectious Diseases 442
  • Molecular Biology 107
  • Animal Science and Zoology 97
  • Health 91
  • Immunology 72
Replace Adam Brosz with:
Adam Brosz United States
Nichole McGhee United States
Alina Seidel Germany
Andrea Sutherland United States
Bethany Girard United States
Justin DaSilva United States
Ann-Kathrin Wallisch Germany
Claire Carlin United States
Ying Chang relative to Adam Brosz United States Adam Brosz's profile →
Citations per field
00.5×1.5×
Adam Brosz · 1×
Citations per year

Countries citing papers authored by Ying Chang

Since Specialization
Citations

This map shows the geographic impact of Ying Chang's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ying Chang with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ying Chang more than expected).

Fields of papers citing papers by Ying Chang

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Ying Chang. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ying Chang. The network helps show where Ying Chang may publish in the future.

Co-authorship network of co-authors of Ying Chang

This figure shows the co-authorship network connecting the top 25 collaborators of Ying Chang. A scholar is included among the top collaborators of Ying Chang based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Ying Chang. Ying Chang is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

6 of 6 papers shown
#WorkIndexed citations
1 2
2 11
3 56
4 70
5 5
6
A Bivalent Omicron-Containing Booster Vaccine against Covid-19breakdown →
346

About Ying Chang

Ying Chang is a scholar working on Animal Science and Zoology, Infectious Diseases and Immunology, having authored 6 papers that have together received 490 indexed citations. Recurring topics across this work include SARS-CoV-2 and COVID-19 Research (4 papers), Animal Virus Infections Studies (3 papers) and Immunotherapy and Immune Responses (2 papers). The work is most often cited by research in Infectious Diseases (442 citations), Health (91 citations) and Animal Science and Zoology (97 citations). Ying Chang has collaborated with scholars based in United States, China and United Kingdom. Frequent co-authors include Jacqueline M. Miller, Bethany Girard, Rituparna Das, Darin K. Edwards, David C. Montefiori, Lindsey R. Baden, Brandon Essink, Xing Chen, Haiyu Zhou and Jing Feng. Their work appears in journals such as New England Journal of Medicine, Nature Medicine and Nature Communications.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026